AstraZeneca Pty Ltd
Regulatory activities for this sponsor.
Loading...
Sponsor content
317 result(s) found, displaying 11 to 20
-
Dec-2024Prescription medicine evaluationActive ingredient: Influenza virus.
-
Prescription medicine registrationActive ingredients: osimertinib mesilate.
-
Cancellation by sponsorRequested by AstraZeneca Pty Ltd
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ARX-Ticagrelor ticagrelor 90 mg tablet blister pack.
-
Nov-2024Prescription medicine evaluationActive ingredient: trastuzumab deruxtecan.
-
Prescription medicine registrationActive ingredients: osimertinib mesilate.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SIDAPVIA 10/100 dapagliflozin 10 mg (as propanediol monohydrate)/sitagliptin 100 mg (as phosphate monohydrate) film coated tablets blister pack.
-
Australian Public Assessment Report (AusPAR)Lokelma (sodium zirconium cyclosilicate hydrate) was approved for the treatment of hyperkalaemia (high potassium levels in blood) in adult patients.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for TRUQAP capivasertib 200 mg film coated tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for TRUQAP capivasertib 160 mg film coated tablet blister pack.